Vitria is a phosphodiesterase type 5 inhibitor used primarily for the treatment of erectile dysfunction. Its definition includes that it selectively blocks the enzyme phosphodiesterase 5 in smooth muscle cells. By inhibiting this enzyme, the drug prevents the breakdown of cyclic guanosine monophosphate, allowing it to accumulate. The increased cyclic gmp leads to relaxation of penile smooth muscle and enhanced blood flow. This physiological response facilitates the achievement and maintenance of an erection during sexual stimulation. The therapeutic purpose of Vitria therefore focuses on improving erectile function in adult men with impotence. Pharmacodynamically, the medication's action is characterized by a dose-dependent increase in the duration of vasodilation mediated by nitric oxide signaling.

Vitria is a prescription drug classified as a phosphodiesterase type 5 inhibitor used to treat erectile dysfunction. The medication works by relaxing smooth muscle tissue in the pelvic region to increase blood flow. It achieves this effect by blocking the enzyme phosphodiesterase 5 which normally breaks down cyclic guanosine monophosphate. Elevated levels of cyclic guanosine monophosphate promote vasodilation and facilitate an erection in response to sexual stimulation. Pharmacodynamically Vitria produces a reversible inhibition that begins shortly after oral administration and lasts for several hours. Through selective interaction with vascular smooth muscle the drug helps restore normal erectile function without directly stimulating sexual desire.

Common side effects of Vitria may include mild headache dizziness or nausea and occasional fatigue. Some users report temporary digestive discomfort such as stomach upset or reduced appetite. Occasionally mild skin irritation or itching can appear at the application site. Headaches are frequently mentioned alongside occasional dry mouth sensations. Fatigue or mild weakness are also noted without being severe. Most reported effects are short lived and resolve without further issues.

Vitria may cause mild gastrointestinal discomfort such as nausea and indigestion. Some users report temporary headaches or dizziness during the initial adjustment period. A small percentage experience mild skin irritation or itching at the application site. Occasional sleep disturbances have been noted, particularly if taken late in the day. Rare reports include mild allergic reactions with rash or swelling. Most side effects are transient and typically resolve without medical intervention. Long-term safety data remains limited, emphasizing the importance of monitoring symptom changes